rs143181834

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_145038.5(DRC1):​c.992C>T​(p.Thr331Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00418 in 1,612,912 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0074 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 29 hom. )

Consequence

DRC1
NM_145038.5 missense

Scores

2
6
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.94

Publications

7 publications found
Variant links:
Genes affected
DRC1 (HGNC:24245): (dynein regulatory complex subunit 1) This gene encodes a central component of the nexin-dynein complex (N-DRC), which regulates the assembly of ciliary dynein. Mutations in this gene can cause ciliary dyskinesia. [provided by RefSeq, Aug 2015]
DRC1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 21
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • spermatogenic failure 80
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047012568).
BP6
Variant 2-26440481-C-T is Benign according to our data. Variant chr2-26440481-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 414289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00738 (1122/152096) while in subpopulation AFR AF = 0.0191 (792/41484). AF 95% confidence interval is 0.018. There are 7 homozygotes in GnomAd4. There are 525 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC1NM_145038.5 linkc.992C>T p.Thr331Ile missense_variant Exon 8 of 17 ENST00000288710.7 NP_659475.2 Q96MC2
DRC1XM_047446339.1 linkc.9-3741C>T intron_variant Intron 1 of 9 XP_047302295.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DRC1ENST00000288710.7 linkc.992C>T p.Thr331Ile missense_variant Exon 8 of 17 2 NM_145038.5 ENSP00000288710.2 Q96MC2

Frequencies

GnomAD3 genomes
AF:
0.00737
AC:
1120
AN:
151978
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0191
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00779
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00704
Gnomad FIN
AF:
0.000378
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00319
Gnomad OTH
AF:
0.00527
GnomAD2 exomes
AF:
0.00502
AC:
1260
AN:
251078
AF XY:
0.00491
show subpopulations
Gnomad AFR exome
AF:
0.0195
Gnomad AMR exome
AF:
0.00409
Gnomad ASJ exome
AF:
0.00826
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.00324
Gnomad OTH exome
AF:
0.00669
GnomAD4 exome
AF:
0.00385
AC:
5625
AN:
1460816
Hom.:
29
Cov.:
33
AF XY:
0.00396
AC XY:
2881
AN XY:
726738
show subpopulations
African (AFR)
AF:
0.0196
AC:
657
AN:
33440
American (AMR)
AF:
0.00392
AC:
175
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.00958
AC:
250
AN:
26084
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39656
South Asian (SAS)
AF:
0.0104
AC:
896
AN:
86042
European-Finnish (FIN)
AF:
0.000675
AC:
36
AN:
53364
Middle Eastern (MID)
AF:
0.00867
AC:
50
AN:
5764
European-Non Finnish (NFE)
AF:
0.00295
AC:
3275
AN:
1111450
Other (OTH)
AF:
0.00474
AC:
286
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
310
619
929
1238
1548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00738
AC:
1122
AN:
152096
Hom.:
7
Cov.:
32
AF XY:
0.00706
AC XY:
525
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.0191
AC:
792
AN:
41484
American (AMR)
AF:
0.00236
AC:
36
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00779
AC:
27
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00705
AC:
34
AN:
4826
European-Finnish (FIN)
AF:
0.000378
AC:
4
AN:
10574
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00319
AC:
217
AN:
67996
Other (OTH)
AF:
0.00522
AC:
11
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
54
107
161
214
268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00411
Hom.:
4
Bravo
AF:
0.00836
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.0207
AC:
91
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00553
AC:
671
Asia WGS
AF:
0.00404
AC:
15
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 19, 2024
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 21 Benign:1
May 12, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
23
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.048
T
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.76
T
MetaRNN
Benign
0.0047
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Pathogenic
3.1
M
PhyloP100
2.9
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-4.2
D
REVEL
Benign
0.14
Sift
Uncertain
0.0080
D
Sift4G
Benign
0.092
T
Polyphen
1.0
D
Vest4
0.27
MVP
0.35
MPC
0.14
ClinPred
0.021
T
GERP RS
4.3
Varity_R
0.16
gMVP
0.30
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143181834; hg19: chr2-26663349; API